Copyright
©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 107873
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.107873
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.107873
Figure 1 Timeline of eligibility criteria for liver transplantation.
Figure 2 Transarterial chemoembolization performed with cone beam computed tomography.
A: Cone beam computed tomography showing a nodule with contrast enhancement located in S4 with EmboGuide Software allowing the identification of the route (yellow line) from catheter tip to lesion; B: EmboGuide reconstruction; C: Angiography demonstrating catheterization of the lesion-feeder vessel.
Figure 3 69-year-old man with hepatocellular carcinoma unfit for surgery due to comorbidities.
A: Computed tomography (CT) showing hepatocellular carcinoma nodule (5-6 cm) located in S2; B: Cone beam CT demonstrating superselective catheterization of the segmental S2 artery with perfused nodule; C: Single-photon emission tomography combined with CT showing 99mTc-MAA uptake into S2; D: 12-months CT follow-up scan showing complete nodule necrosis with no contrast enhancement and atrophy of the treated liver lobe (radiation segmentectomy).
- Citation: Cortese F, Anagnostopoulos F, Bazzocchi MV, Caringi S, Pisani AR, Renzulli M, Paraskevopoulos I, Laera L, Surgo A, Spiliopoulos S, Memeo R, Inchingolo R. Modern approach to hepatocellular carcinoma treatment. World J Hepatol 2025; 17(8): 107873
- URL: https://www.wjgnet.com/1948-5182/full/v17/i8/107873.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i8.107873